Trial Profile
A Phase 2, Double-Blind, Placebo-Controlled, 3-Month Trial of LY3298176 Versus Placebo in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2021
Price :
$35
*
At a glance
- Drugs Tirzepatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 08 Jun 2019 According to an Eli Lilly media release, results from this study were presented in oral and poster presentations at the American Diabetes Association's 79th Scientific Sessions.
- 08 Jun 2019 Results published in the Eli Lilly Media Release.